Intra-Cellular Therapies Inc (ITCI)
72.04
-4.65
(-6.06%)
USD |
NASDAQ |
Apr 18, 16:00
72.04
0.00 (0.00%)
After-Hours: 16:57
Intra-Cellular Therapies Total Return Price: 72.04 for April 18, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 17, 2024 | 76.69 |
| April 16, 2024 | 79.84 |
| April 15, 2024 | 64.76 |
| April 12, 2024 | 65.88 |
| April 11, 2024 | 67.97 |
| April 10, 2024 | 67.28 |
| April 09, 2024 | 68.62 |
| April 08, 2024 | 67.70 |
| April 05, 2024 | 68.44 |
| April 04, 2024 | 67.21 |
| April 03, 2024 | 67.32 |
| April 02, 2024 | 66.67 |
| April 01, 2024 | 68.27 |
| March 28, 2024 | 69.20 |
| March 27, 2024 | 69.72 |
| March 26, 2024 | 67.33 |
| March 25, 2024 | 67.97 |
| March 22, 2024 | 69.02 |
| March 21, 2024 | 68.38 |
| March 20, 2024 | 67.21 |
| March 19, 2024 | 65.45 |
| March 18, 2024 | 65.37 |
| March 15, 2024 | 64.78 |
| March 14, 2024 | 64.57 |
| March 13, 2024 | 65.21 |
| Date | Value |
|---|---|
| March 12, 2024 | 64.37 |
| March 11, 2024 | 65.43 |
| March 08, 2024 | 67.48 |
| March 07, 2024 | 66.72 |
| March 06, 2024 | 66.03 |
| March 05, 2024 | 66.62 |
| March 04, 2024 | 67.23 |
| March 01, 2024 | 71.49 |
| February 29, 2024 | 69.52 |
| February 28, 2024 | 71.13 |
| February 27, 2024 | 72.90 |
| February 26, 2024 | 71.56 |
| February 23, 2024 | 70.16 |
| February 22, 2024 | 71.93 |
| February 21, 2024 | 73.28 |
| February 20, 2024 | 73.70 |
| February 16, 2024 | 75.65 |
| February 15, 2024 | 74.89 |
| February 14, 2024 | 71.99 |
| February 13, 2024 | 70.40 |
| February 12, 2024 | 72.73 |
| February 09, 2024 | 72.77 |
| February 08, 2024 | 71.60 |
| February 07, 2024 | 68.57 |
| February 06, 2024 | 70.09 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
7.26
Minimum
Oct 01 2019
79.84
Maximum
Apr 16 2024
39.47
Average
40.34
Median
Jul 08 2021
Total Return Price Benchmarks
| Insmed Inc | 24.79 |
| Fate Therapeutics Inc | 5.035 |
| ADMA Biologics Inc | 6.205 |
| Rhythm Pharmaceuticals Inc | 38.10 |
| Amylyx Pharmaceuticals Inc | 1.97 |